Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-18,222
Closed -$696K – 549
2016
Q3
$696K Sell
18,222
-21,980
-55% -$882K 0.04% 280
2016
Q2
$1.68M Sell
40,202
-16,530
-29% -$678K 0.09% 188
2016
Q1
$2.28M Buy
56,732
+6,970
+14% +$280K 0.15% 155
2015
Q4
$2.12M Sell
49,762
-9,665
-16% -$445K 0.1% 163
2015
Q3
$2.82M Sell
59,427
-816
-1% -$41.5K 0.19% 126
2015
Q2
$2.98M Sell
60,243
-61
-0.1% -$3.09K 0.19% 121
2015
Q1
$2.98M Buy
60,304
+295
+0.5% +$14.1K 0.18% 132
2014
Q4
$2.74M Buy
60,009
+5,885
+11% +$286K 0.17% 135
2014
Q3
$3.05M Sell
54,124
-987
-2% -$53K 0.19% 127
2014
Q2
$2.93M Sell
55,111
-2,338
-4% -$124K 0.19% 132
2014
Q1
$3M Buy
57,449
+322
+0.6% +$16.3K 0.21% 119
2013
Q4
$3.06M Sell
57,127
-6,704
-11% -$346K 0.21% 107
2013
Q3
$3.23M Sell
63,831
-490
-0.8% -$24.9K 0.23% 106
2013
Q2
$3.31M Buy
+64,321
New +$3.43M 0.25% 93

Other funds holding SNY

Curi RMB Capital's SNY Position: Q4 2016 in Review

Curi RMB Capital sold out of Sanofi (SNY) in Q4 2016, closing a stake of 18,222 shares — an estimated $696K sold.

Curi RMB Capital first reported a position in SNY in Q2 2013 and held it in 14 quarters. The position peaked at $3.31M in Q2 2013. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

  • Curi RMB Capital reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
  • Curi RMB Capital sold 18,222 Sanofi shares in Q4 2016, an estimated $696K.
  • Curi RMB Capital first reported a position in Sanofi in Q2 2013 and held it in 14 quarters.
  • Curi RMB Capital's Sanofi position peaked at $3.31M in Q2 2013.
  • 476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Curi RMB Capital's 13F filing for Q4 2016, filed 13 Feb 2017.